Z
Zymeworks
Biotech & Life Sciences · Vancouver, Canada · Founded 2003 · IPO 2017
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics MoreLess
Zymeworks is a biopharmaceutical company focused on developing multifunctional therapeutics for patients with difficult-to-treat cancers and other serious diseases. Operating in the biotechnology sector, Zymeworks serves healthcare providers, research institutions, and pharmaceutical companies. The company leverages its proprietary technology platforms to create antibody-drug conjugates and multispecific antibody therapeutics. Zymeworks generates revenue through partnerships, collaborations, and licensing agreements with other pharmaceutical companies, as well as through the commercialization of its own therapeutic products. The company's integrated R&D engine, from target selection to pivotal studies, is driven by a team of world-class researchers dedicated to discovering, developing, and commercializing novel agents globally.
Keywords: biopharmaceutical, multifunctional therapeutics, antibody-drug conjugates, multispecific antibodies, biotechnology, cancer treatment, serious diseases, R&D, partnerships, commercialization.
Talent graph
Zymeworks's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Zymeworks has talent and traffic
team presence
across markets
Patent intelligence
$125M patent portfolio · 84 active families
Where Zymeworks concentrates vs peers
Each axis is a top-10 topic across Zymeworks and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Zymeworks
An AI-synthesized read of the highest-engagement posts about Zymeworks on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zymeworks on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.